BioCentury
ARTICLE | Clinical News

Manufacturing facility regulatory update

December 13, 1999 8:00 AM UTC

REGN received FDA approval as a contract manufacturer of an intermediate for an existing pediatric vaccine from Merck & Co. Inc. (Whitehouse Station, N.J.). Under its supply agreement with Merck, REG...